Player FM ऐप के साथ ऑफ़लाइन जाएं!
Episode 23. Bispecific Antibodies in Myeloma
Manage episode 364812224 series 3369804
In this episode, we delve into the latest data on bispecific antibodies in multiple myeloma with Dr. Ajai Chari. Here are the key studies discussed:
1. Teclistamab (MajesTEC-1 trial): https://pubmed.ncbi.nlm.nih.gov/35661166/
2. Correlative analysis from MajesTEC-1 trial: https://ashpublications.org/blood/article/140/Supplement%201/241/487619
3. Talquetamab (MonumenTAL-1 trial): https://pubmed.ncbi.nlm.nih.gov/36507686/
4. Phase 1 trial of fixed-duration cevostamab:
https://ashpublications.org/blood/article/140/Supplement%201/4415/492339
5. Phase 1 trial of ABBV-383: https://pubmed.ncbi.nlm.nih.gov/36029527/
6. Paper summarizing infections with different bispecific antibodies in myeloma: https://pubmed.ncbi.nlm.nih.gov/36716411/
51 एपिसोडस
Manage episode 364812224 series 3369804
In this episode, we delve into the latest data on bispecific antibodies in multiple myeloma with Dr. Ajai Chari. Here are the key studies discussed:
1. Teclistamab (MajesTEC-1 trial): https://pubmed.ncbi.nlm.nih.gov/35661166/
2. Correlative analysis from MajesTEC-1 trial: https://ashpublications.org/blood/article/140/Supplement%201/241/487619
3. Talquetamab (MonumenTAL-1 trial): https://pubmed.ncbi.nlm.nih.gov/36507686/
4. Phase 1 trial of fixed-duration cevostamab:
https://ashpublications.org/blood/article/140/Supplement%201/4415/492339
5. Phase 1 trial of ABBV-383: https://pubmed.ncbi.nlm.nih.gov/36029527/
6. Paper summarizing infections with different bispecific antibodies in myeloma: https://pubmed.ncbi.nlm.nih.gov/36716411/
51 एपिसोडस
Alle Folgen
×प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।